Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced the Strata Precision Indications for Approved Therapies, or “Strata PATH,” trial.